A Novel Liver Cancer-Selective Histone Deacetylase Inhibitor Is Effective against Hepatocellular Carcinoma and Induces Durable Responses with Immunotherapy is a research paper published in ACS Pharmacology & Translational Science (2024). On theSindex it has a DataRank of 0. It has been cited 5 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
Division of Intramural Research, National Institute of Allergy and Infectious Diseases
Grant: P01CA261669
Division of Intramural Research, National Institute of Allergy and Infectious Diseases
Grant: R01CA131217
Division of Intramural Research, National Institute of Allergy and Infectious Diseases
Grant: R01CA247441
Division of Intramural Research, National Institute of Allergy and Infectious Diseases
Grant: R01CA254351
Division of Intramural Research, National Institute of Allergy and Infectious Diseases
Grant: R01CA260857
Division of Intramural Research, National Institute of Allergy and Infectious Diseases
Grant: R01CA266013
Division of Intramural Research, National Institute of Allergy and Infectious Diseases
Grant: R03CA256764
Division of Intramural Research, National Institute of Allergy and Infectious Diseases
Grant: R43CA224642
U.S. Department of Defense
Grant: W81XWH-19-1-0284
U.S. Department of Defense
Grant: W81XWH-21-1-0738